214 related articles for article (PubMed ID: 7678080)
1. Evaluating prethrombotic state in lung cancer using molecular markers.
Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
[TBL] [Abstract][Full Text] [Related]
2. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
[TBL] [Abstract][Full Text] [Related]
3. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
Nagayama M; Tachibana A; Hayakawa H; Sato A
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
[TBL] [Abstract][Full Text] [Related]
4. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis.
Seitz R; Rappe N; Kraus M; Immel A; Wolf M; Maasberg M; Egbring R; Pfab R; Havemann K
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):249-54. PubMed ID: 8388741
[TBL] [Abstract][Full Text] [Related]
5. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
[TBL] [Abstract][Full Text] [Related]
6. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
7. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
8. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
9. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
Wada H; Ikuma H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Onoda K; Yamada N; Ohta T; Nishioka J; Sakuragawa N; Shiku H
Semin Thromb Hemost; 2000; 26(1):113-8. PubMed ID: 10805292
[TBL] [Abstract][Full Text] [Related]
10. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
Masago K; Fujita S; Mio T; Togashi Y; Kim YH; Hatachi Y; Fukuhara A; Irisa K; Sakamori Y; Mishima M
Med Oncol; 2011 Mar; 28(1):351-6. PubMed ID: 20300980
[TBL] [Abstract][Full Text] [Related]
13. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer.
Taguchi O; Gabazza EC; Yoshida M; Yamakami T; Kobayashi H; Shima T
Clin Chim Acta; 1996 Jan; 244(1):69-81. PubMed ID: 8919202
[TBL] [Abstract][Full Text] [Related]
14. Studies on changes in parameters of the coagulation and fibrinolysis in association with extracorporeal shock wave lithotripsy.
Umekawa T; Kohri K; Yamate T; Amasaki N; Ishikawa Y; Kurita T
Urol Int; 1993; 50(3):159-63. PubMed ID: 8465483
[TBL] [Abstract][Full Text] [Related]
15. Blood coagulation and fibrinolysis in eclamptic patients and their correlation with the clinical signs.
Halim A; Bhuiyan AB; Azim FA; Khatun S; Kanayama N; el Maradny E; Maehara K; Hiroshi K; Terao T
Gynecol Obstet Invest; 1995; 39(2):97-102. PubMed ID: 7772198
[TBL] [Abstract][Full Text] [Related]
16. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
[TBL] [Abstract][Full Text] [Related]
18. Hemostasis in newborns of smoking and nonsmoking mothers.
Mercelina-Roumans PE; Ubachs JM; van Wersch JW
Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
[TBL] [Abstract][Full Text] [Related]
19. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
Koike K; Fujimaki M
Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]